MedPath

Ureteral Stent Study

Not Applicable
Completed
Conditions
Urolithiasis
Registration Number
NCT03043612
Lead Sponsor
Cook Group Incorporated
Brief Summary

The purpose of this study is to evaluate the feasibility of the Cook Ureteral Stent to reduce post-stent placement pain and urinary symptoms in patients following ureteroscopy for urolithiasis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Patient is undergoing ureteroscopy for urolithiasis in which temporary ureteral stenting is indicated
Exclusion Criteria
  • Patient is unwilling or unable to sign and date the informed consent
  • Patient is unwilling to comply with the follow-up study schedule
  • Patient is pregnant, breast-feeding, or planning to become pregnant during the course of the study
  • Patient is currently taking anti-cholinergic or other anti-spasm medications
  • Patient is currently taking sildenafil, tadalafil, or vardenafil
  • Patient has a known sensitivity to alpha-blocker medications
  • Patient is currently undergoing chemotherapy or radiation therapy
  • Patient has an active urinary tract infection
  • Patient is in chronic renal failure, on hemodialysis, or on chronic peritoneal dialysis
  • Patient requires bilateral shock wave lithotripsy, bilateral stents, or has bilateral symptomatic kidney stones
  • Patient has had a ureteral stent within the past three months in either ureter
  • Patient is unable to accurately detect or report bladder function or pain
  • Patient has chronic pain

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Patient-reported body pain score7-days post stent placement

Comparing the patient-reported body pain score from the USSQ 1 survey between the two study arms

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Prince of Wales/Chinese University of Hong Kong

🇭🇰

Sha Tin, Hong Kong

Prince of Wales/Chinese University of Hong Kong
🇭🇰Sha Tin, Hong Kong

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.